Get Adobe Flash player


Founder and CEO

Raanan Margalit

Raanan Margalit has over 25 years of experience at the Weizmann Institute of Science where he gained knowledge and expertise in immunology molecular biology, and cell biology. Raanan specializes in the development and utilization of animal models for early stage drug discovery, with special emphasis on autoimmune and inflammatory diseases, cancer, neurodegenerative disorders as well as disease models involving surgical procedures and/or transplantation. His work has been published in over 50 peer reviewed journals. Raanan Margalit has extensive experience in accompanying biopharma companies from inception, providing solutions and guiding company management through the early stages of preclinical development to the demonstration of proof of concept in relevant animal models.


Scientific Advisory Board

Prof. Irun R. Cohen, M.D.  

Prof. Irun R. Cohen of the Weizmann Institute of Science is a world-renowned expert in the field of immunology and is a leading authority on auto-immune diseases. Prof. Cohen’s research on the development of novel immune-based therapeutics is currently under advanced clinical development for neuro-degenerative and inflammatory diseases.


Bioinformatics Advisor

Chai Ezerzer

Dr. Chai Ezerzer pioneered the concept of balance in the chemokine network and developed a systems biology and bioinformatics infrastructure for validation in animal models of disease. Dr. Ezerzer has developed algorithm-generated peptides designed to interact with disease-related proteins and proprietary High Through-Put Array (HTA) screen for validation of therapeutic potential and antigenic indication.


Development Advisor

Binah R. Baum, business

Dr. Binah R. Baum is the managing director of TMI, a consultancy specializing in promotion and externalization of technologies from Israel to Europe for incubation and further business expansion. Highly skilled in the university industry interface, commercialization of biomedical technologies and creation and nurturing of early-stage companies and incubator startups.